1. Home
  2. PRPL vs PYPD Comparison

PRPL vs PYPD Comparison

Compare PRPL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.70

Market Cap

76.9M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.20

Market Cap

77.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
PYPD
Founded
2010
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
77.4M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PRPL
PYPD
Price
$0.70
$4.20
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$1.00
$12.00
AVG Volume (30 Days)
203.9K
48.8K
Earning Date
05-05-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
22.22
N/A
EPS
0.45
N/A
Revenue
$487,877,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.69
N/A
P/E Ratio
$1.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$2.30
52 Week High
$1.26
$5.12

Technical Indicators

Market Signals
Indicator
PRPL
PYPD
Relative Strength Index (RSI) 49.25 43.87
Support Level $0.65 $4.01
Resistance Level $0.74 $4.38
Average True Range (ATR) 0.04 0.19
MACD 0.00 0.01
Stochastic Oscillator 55.07 17.60

Price Performance

Historical Comparison
PRPL
PYPD

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: